LENSAR, Inc.

Healthcare

NASDAQ:LNSR · NASDAQ Capital Market

Market Cap $68.69M Beta 0.87 P/E (TTM) 2.4

$5.82 +0.00%

+$0.00 today

52W Low $5.06High $13.47

Vol 0.03M · Avg 0.12M

EPS (TTM)$2.42

Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-53.44%

Period High

$13.32

Period Low

$5.09

Latest

$5.82

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Anteris Technologies Global Corp.

NASDAQ:AVR

$336.61M

Profound Medical Corp.

NASDAQ:PROF

$200.47M

Anika Therapeutics, Inc.

NASDAQ:ANIK

$195.86M

TriSalus Life Sciences, Inc.

NASDAQ:TLSI

$142.92M

MaxCyte, Inc.

NASDAQ:MXCT

$119.98M

Cardiff Oncology, Inc.

NASDAQ:CRDF

$105.29M

Corbus Pharmaceuticals Holdings, Inc.

NASDAQ:CRBP

$102.67M

Owlet, Inc.

NYSE:OWLT

$84.14M

Rapid Micro Biosystems, Inc.

NASDAQ:RPID

$79.77M

Accuray Incorporated

ARAY

$40.60M

What is the latest LNSR filing?

The latest filing shown is 4 dated Jun 5, 2026.

How many recent filings does LNSR have?

Intrinsic Alpha currently shows 20 recent filings for LNSR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.